Oxazolone-induced colitis in rats: Effects of budesonide, cyclosporin A, and 5-aminosalicylic acid

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 2, 1998, Pages 174-179

  Ekstrom G M ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

5 Aminosalicylic acid; Budesonide; Carmellose sodium; Contact hypersensitivity; Cyclosporin A; Dark Agouti rats; Delayed type hypersensitivity; Experimental model; Inflammatory bowel diseases; Oxazolone; Prednisolone

Indexed keywords

ANTIINFLAMMATORY AGENT; BUDESONIDE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MESALAZINE; MYELOPEROXIDASE; OXAZOLONE; PREDNISOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECTAL DRUG ADMINISTRATION;

ANIMALS; BUDESONIDE; COLITIS; COLON; CYCLOSPORINE; DISEASE MODELS, ANIMAL; FEMALE; INTESTINAL MUCOSA; MESALAMINE; ORGAN SIZE; OXAZOLONE; PEROXIDASE; RATS; TIME FACTORS;

EID: 0031933806     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529850166914     Document Type: Article

References (29)

1. Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Inflam Bowel Dis 1995;3 475-507.
2. MacDermott RP. Alterations in the mucosal immune system in ulcerative colitis and Crohn's disease. Inflam Bowel Dis 1994; 6:1207-31.
3. Shanahan F. Pathogenesis of ulcerative colitis. Lancet 1993; 314:407-11.
4. Sartor RB. Lessons in IBD pathogenesis from new animal models of spontaneous colitis. Can J Gastroenterol 1995;6:309-15.
5. Sartor RB. Animal models of intestinal inflammation. Relevance to inflammatory bowel disease. In: MacDermott RP, Stenson WF, editors. Inflammatory bowel disease. New York: Elsevier Science Publ; 1992. p. 337-53.
6. Grisham MB. Animal models of inflammatory bowel disease. Cur Opin Gastroenterol 1993;9:524-33.
7. Kim H-S, Berstad A. Experimental colitis in animal models. Scand J Gastroenterol 1992;27:529-37.
8. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795-803.
9. Yamada T, Marshall S, Specian RD, Grisham MB. A comparative analysis of two models of colitis in rats. Gastroenterology 1992;102:1524-34.
10. Axelsson L-G. Experimental animal models for the study of inflammatory bowel diseases and gastrointestinal anti-inflammatory drugs [thesis]. Uppsala: Faculty of Science and Technology, Uppsala University; 1996. p. 1-62.
11. Conner EM, Grisham MB. Animal models of colitis. In: Gaginella TS, editor. Experimental models of mucosal inflammation. Boca Raton (FL): CRC Press; 1996.
12. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Analyt Biochem 1983;132:345-52.
13. Axelsson L-G, Ahlstedt S. Actions of sulphasalazine and analogues in animal models of experimental colitis. Inflamm Pharmacol 1993;2:2219-32.
14. Obersnel D, Groselj D. An adhesive ointment base. Farm Vestn 1987;38:37-40.
15. Sveinsson SJ, Mezei M. In vitro oral mucosal absorption of liposomal triamcinolone acetonide. Pharm Res 1992;9:1359-61.
16. Bicks RO, Brown G, Hickey HD Jr, Rosenberg EW. Further observations on a delayed hypersensitivity reaction in the guinea pig colon. Gastroenterology 1965;48:425-9.
17. Bicks RO, Azar MM, Rosenberg EW, Dunham WG, Luther J. Delayed hypersensitivity reactions in the intestinal tract. I. Studies of 2,4-dinitrochlorobenzene-caused guinea-pig and swine colon lesions. Gastroenterology 1965;53:422-36.
18. - T cells. J Exp Med 1996;183:1001-12.
19. Friedlaender MH, Cyr R. Contact sensitivity in the guinea pig eye. Curr Eye Res 1981;1:403-7.
20. Hall JG. Effect of skin painting with oxazolone on the local extravasation of mononuclear cells in sheep. Ciba Found Symp 1980;71:197-209.
21. Ahlfors E, Czerkinsky C. Contact sensitivity in the murine oral mucosa. I. An experimental model of delayed-type hypersensitivity reactions at mucosal surfaces. Clin Exp Immunol 1991; 86:449-56.
22. DeBrito FB, Hanahoe TH, Shah P, West GB. Delayed hypersensitivity reactions in rats and their response to clinical dextran. Int Arch Allergy Appl Immunol 1982;69:109-12.
23. Askenase PW. Delayed-type hypersensitivity recruitment of T cell subsets via antigen-specific non-IgE factors or IgE antibodies: relevance to asthma, autoimmunity and immune responses to tumors and parasites. In: Regulation and functional significance of T-cell subsets. Chem Immunol 1992;54:166-211.
24. Van Loveren H, Askenase PW. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities. J Immunol 1984;5:2397-401.
25. Selve N. Chronic intrajejunal TNBS application in TNBS-sensitized rats: a new model of chronic inflammatory bowel diseases. Agents Actions 1992 (Spec Conf Iss).
26. Selve N, Wöhrmann T. Intestinal inflammation in TNBS sensitized rats as a model of chronic inflammatory bowel disease. Mediat Inflam 1992;1:121-6.
27. Brkić T, Banić M, Anić B, Grbarević Ž, Rotkvić I, Artuković B, et al. A model of inflammatory bowel disease induced by 2,4-dinitrofluorobenzene in previously sensitized BALB-c mice. Scand J Gastroenterol 1992;27:184-8.
28. Larsson P, Kleinau S, Holmdahl R, Klareskog L. Homologous type II collagen-induced arthritis in rats: characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation. Arthritis Rheum 1990;33:693-701.
29. Lorentzen JC, Issazadeh S, Storch M, Mustafa MI, Lassman H, Linington C, et al. Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant. J Neuroimmunol 1995;63:193-205.